SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-20-011097
Filing Date
2020-05-08
Accepted
2020-05-08 16:02:35
Documents
64
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q form10q.htm 10-Q 1045610
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 10371
3 EXHIBIT 31.2 ex31_2.htm EX-3.2 10339
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 5489
11 image1.jpg GRAPHIC 63184
  Complete submission text file 0001140361-20-011097.txt   5214702

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT rckt-20200331.xml EX-101.INS 879628
6 XBRL TAXONOMY EXTENSION SCHEMA rckt-20200331.xsd EX-101.SCH 46901
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rckt-20200331_cal.xml EX-101.CAL 61627
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rckt-20200331_def.xml EX-101.DEF 223291
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE rckt-20200331_lab.xml EX-101.LAB 683072
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rckt-20200331_pre.xml EX-101.PRE 348733
Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Filer) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36829 | Film No.: 20860462
SIC: 2834 Pharmaceutical Preparations